UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 2)
KIRSCHNER MEDICAL CORPORATION
(Name of Issuer)
Common Stock, $.10 Par Value
(Title of Class of Securities)
497660 10 0
(CUSIP Number)
Daniel P. Hann, Biomet, Inc.
Airport Industrial Park, P.O. Box 587
Warsaw, Indiana 46580 (800) 348-9500
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
August 12, 1994
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule l3D, and is filing this
schedule because of Rule l3d-1(b)(3) or (4), check the following box __.
Check the following box if a fee is being paid with the statement __. (A fee
is not required only if the reporting person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule l3d-l(a) for other parties to whom copies are to be
sent.
The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act
of 1934 ("Act") or otherwise subject to the liabilities of that section of the
Act but shall be subject to all other provisions of the Act (however, see the
Notes).
Total pages: ________
SCHEDULE 13D
CUSIP No. 497660 10 0 Page _________ of _________ Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Biomet, Inc. 35-1480613
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ___
(b) _X_
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS
WC
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(D)OR 2(E) ___
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OR ORGANIZATION
U.S.A.
- --------------------------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
685,222
- --------------------------------------------------------------------------------
8 SHARED VOTING POWER
-0-
- --------------------------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
685,222
- --------------------------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
-0-
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON
685,222
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
EXCLUDES CERTAIN SHARES ___
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
19.0%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
CO
- --------------------------------------------------------------------------------
SEE INSTRUCTIONS BEFORE FILLING OUT! INCLUDE BOTH SIDES OF
THE COVER PAGE, RESPONSES TO ITEMS 1-7 (INCLUDING EXHIBITS)
OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
- --------------------------------------------------------------------------------
SCHEDULE 13D
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Kirschner Acquisition Corp. 35-1928713
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ___
(b) _X_
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS
AF
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(D)OR 2(E) ___
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OR ORGANIZATION
U.S.A.
- --------------------------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
685,222
- --------------------------------------------------------------------------------
8 SHARED VOTING POWER
-0-
- --------------------------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
685,222
- --------------------------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
-0-
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON
685,222
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
EXCLUDES CERTAIN SHARES ___
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
19.0%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
CO
- --------------------------------------------------------------------------------
SEE INSTRUCTIONS BEFORE FILLING OUT! INCLUDE BOTH SIDES OF
THE COVER PAGE, RESPONSES TO ITEMS 1-7 (INCLUDING EXHIBITS)
OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
- --------------------------------------------------------------------------------
Item 7. Material to be Filed as Exhibits
Page in Sequential
Description of Exhibits Numbering System
----------------------- ------------------
Purchase Agreement dated August 12,
1994 by and between Figgie
International, Inc. and Kirschner
Acquisition Corp. (1)
Agreement and Plan of Merger by and
among Biomet, Inc., Biomet
Acquisition Corp and Kirschner
Medical Corporation, dated July 16,
1994. (Incorporated by reference
to Exhibit 2 to Kirschner Medical
Corporation's Form 8-K Report dated
July 29, 1994.) (2)
First Amendment to Agreement and
Plan of Merger by and among Biomet,
Inc., Biomet Acquisition Corp.,
Kirschner Acquisition Corp. and
Kirschner Medical Corporation,
dated September 15, 1994. (1)
_____________________________
1 Previously filed.
2 The Agreement and Plan of Merger filed as an
exhibit to Schedule 13D filed on behalf of Kirschner
Medical Corporation on August 20, 1994, is hereby deleted.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.
BIOMET, INC.
Date: October 20, 1994 By: /s/ Gregory D. Hartman
---------------------------
Gregory D. Hartman
Vice President (Finance)
KIRSCHNER ACQUISITION CORP.
Date: October 20, 1994 By: /s/ Gregory D. Hartman
-----------------------------
Gregory D. Hartman, Treasurer
